Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats
Heidi N. Boyda, Ric M. Procyshyn, Lurdes Tse, et al.
Journal of Psychiatry and Neuroscience (2012) Vol. 37, Iss. 6, pp. 407-415
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Joanne Y.T. Leung, Alasdair M. Barr, Ric M. Procyshyn, et al.
Pharmacology & Therapeutics (2012) Vol. 135, Iss. 2, pp. 113-122
Closed Access | Times Cited: 148
Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
Diana Grajales, Vítor Ferreira, Ángela M. Valverde
Cells (2019) Vol. 8, Iss. 11, pp. 1336-1336
Open Access | Times Cited: 136
Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study)
Cynthia Calkin, K. N. Roy Chengappa, Kathleen Cairns, et al.
The Journal of Clinical Psychiatry (2022) Vol. 83, Iss. 2
Open Access | Times Cited: 49
Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
Yueshan Hu, Alan J. Young, Erik A. Ehli, et al.
PLoS ONE (2014) Vol. 9, Iss. 3, pp. e93310-e93310
Open Access | Times Cited: 73
A Focused Review of the Metabolic Side-Effects of Clozapine
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
The IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats
Liying Ren, Xia Zhou, Xiaoqian Huang, et al.
Life Sciences (2018) Vol. 217, pp. 229-236
Closed Access | Times Cited: 57
Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats
Heidi N. Boyda, Alfredo Ramos‐Miguel, Ric M. Procyshyn, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 77-90
Open Access | Times Cited: 48
Obesity exacerbates the acute metabolic side effects of olanzapine
Logan K. Townsend, Willem T. Peppler, Natasha Bush, et al.
Psychoneuroendocrinology (2017) Vol. 88, pp. 121-128
Closed Access | Times Cited: 46
Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism
L Castellani, Kenya A. Costa-Dookhan, William Brett McIntyre, et al.
Journal of Psychiatry and Brain Science (2019)
Open Access | Times Cited: 40
Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial
Sri Mahavir Agarwal, Roshni Panda, Kenya A. Costa-Dookhan, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Treatment of clozapine-associated weight gain: a systematic review
Zachary Whitney, Ric M. Procyshyn, Diane Fredrikson, et al.
European Journal of Clinical Pharmacology (2015) Vol. 71, Iss. 4, pp. 389-401
Closed Access | Times Cited: 40
Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
Heidi N. Boyda, Ric M. Procyshyn, Catherine C.Y. Pang, et al.
PLoS ONE (2013) Vol. 8, Iss. 1, pp. e53459-e53459
Open Access | Times Cited: 39
Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats
Cuilian Guo, Jinxin Liu, Huqun Li
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110912-110912
Open Access | Times Cited: 28
Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration
Katrina Weston‐Green, Ilijana Babic, Michael De Santis, et al.
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 28
Bipolar Disorder and Obesity: Contributing Factors, Impact on Clinical Course, and the Role of Bariatric Surgery
Noreen A. Reilly-Harrington, Emily H. Feig, Jeff C. Huffman
Current Obesity Reports (2018) Vol. 7, Iss. 4, pp. 294-300
Closed Access | Times Cited: 28
Brain insulin action: Implications for the treatment of schizophrenia
Sri Mahavir Agarwal, Chantel Kowalchuk, L Castellani, et al.
Neuropharmacology (2019) Vol. 168, pp. 107655-107655
Closed Access | Times Cited: 28
Effects of chronic exercise and treatment with the antipsychotic drug olanzapine on hippocampal volume in adult female rats
Alasdair M. Barr, Che Hsuan David Wu, Ching Wong, et al.
Neuroscience (2013) Vol. 255, pp. 147-157
Closed Access | Times Cited: 28
Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum
Ana C. Andreazza, Vilte Barakauskas, Salar Fazeli, et al.
Neuroscience Letters (2015) Vol. 591, pp. 36-40
Closed Access | Times Cited: 26
Metformin attenuates olanzapine-induced hepatic, but not peripheral insulin resistance
Gary Remington, Celine Teo, Virginia Wilson, et al.
Journal of Endocrinology (2015) Vol. 227, Iss. 2, pp. 71-81
Open Access | Times Cited: 26
Polyphenol-rich ethyl acetate fraction isolated from Molineria latifolia ameliorates insulin resistance in experimental diabetic rats via IRS1/AKT activation
Der Jiun Ooi, Hadiza Altine Adamu, Mustapha Umar Imam, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 98, pp. 125-133
Open Access | Times Cited: 26
Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis
Chao Luo, Xu Wang, Hanxue Huang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 23
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
Heidi N. Boyda, Amanzo A. Ho, Lurdes Tse, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice
L Castellani, Willem T. Peppler, Paula M. Miotto, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 22
AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis
Natasha Bush, Logan K. Townsend, David C. Wright
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 365, Iss. 3, pp. 526-535
Open Access | Times Cited: 21
AMPK β1 activation suppresses antipsychotic‐induced hyperglycemia in mice
Hesham Shamshoum, Kyle D. Medak, Logan K. Townsend, et al.
The FASEB Journal (2019) Vol. 33, Iss. 12, pp. 14010-14021
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top